Maï, C. K. L., Seferian, A., Taylor, P., Schneider, E., Buhren, B. D., Viard, S. (2025). Real-world data on the management of potentially resectable stage IB-IIIA non-small cell lung cancer (NSCLC) in the United Kingdom (UK) in 2023: Early adoption of immune checkpoint inhibitors (ICIs).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e20618